HomeNewsTechnologyAutoCOVID-19 impact | Getting ready for coronavirus-safe production is the challenge: Apollo Tyres

COVID-19 impact | Getting ready for coronavirus-safe production is the challenge: Apollo Tyres

Plant closures at Apollo Tyres and with rest of the industry had become a norm well before the lockdown

May 04, 2020 / 11:16 IST
Story continues below Advertisement

Apollo Tyres, India’s second-largest tyre producing company, took the lead and announced a partial resumption of operations at three of the six plants in April, even as the nation spends a couple of more weeks under lockdown.

While the domestic demand will not return well past mid-May as per projections, Apollo is working on a new set of guidelines pertaining to safety from coronavirus infection while readapting to its previous norm of ‘stop-n-go’ production.

Story continues below Advertisement

Plant closures at Apollo Tyres and with the rest of the industry had become a norm well before the lockdown was announced by the Centre on March 25, a senior Apollo executive said in an exclusive interaction with Moneycontrol.

Satish Sharma, wholetime director and president (Asia Pacific, Middle East and Africa) - Apollo Tyres, said, “It is not that India’s economy was in the pink of health in the pre-COVID-19 days. We had to stop production for 3-4 days even in those days because sales of M&HCV trucks and cars had gone down substantially. It was a norm back then.”

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show